Elite Diagnostic Limited (JMSE: ELITE)
Jamaica
· Delayed Price · Currency is JMD
2.090
0.00 (0.00%)
At close: Nov 19, 2024
Elite Diagnostic Cash Flow Statement
Financials in millions JMD. Fiscal year is July - June.
Millions JMD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2016 |
Net Income | 20.19 | 26.16 | 13.35 | 48.66 | 1.93 | 8.55 | Upgrade
|
Depreciation & Amortization | 132.43 | 132.16 | 136.5 | 104.93 | 100.01 | 86.78 | Upgrade
|
Other Amortization | 3.07 | 3.07 | -0.06 | 2.59 | 2.05 | 1.4 | Upgrade
|
Other Operating Activities | 3.05 | 3.04 | -0.06 | -0.01 | - | - | Upgrade
|
Change in Accounts Receivable | -31.35 | -25.85 | -57.22 | -17.5 | -0.25 | -16.27 | Upgrade
|
Change in Accounts Payable | 28.35 | 18.17 | 29.88 | 9.56 | 21.95 | -7.75 | Upgrade
|
Change in Other Net Operating Assets | 4.33 | 8.07 | -10.51 | -0.32 | -0.64 | -5.95 | Upgrade
|
Operating Cash Flow | 160.08 | 164.81 | 111.88 | 147.92 | 125.04 | 66.76 | Upgrade
|
Operating Cash Flow Growth | 21.07% | 47.31% | -24.36% | 18.29% | 87.30% | -38.09% | Upgrade
|
Capital Expenditures | -65.11 | -72.53 | -137.75 | -275.79 | -86.24 | -89.28 | Upgrade
|
Other Investing Activities | 0.08 | 0.09 | -20.41 | 0.01 | - | - | Upgrade
|
Investing Cash Flow | -65.04 | -72.44 | -158.15 | -275.78 | -86.24 | -89.28 | Upgrade
|
Short-Term Debt Issued | - | 14.09 | 9.14 | 5.83 | - | - | Upgrade
|
Long-Term Debt Issued | - | - | 365.42 | 190 | - | - | Upgrade
|
Total Debt Issued | 14.09 | 14.09 | 374.56 | 195.83 | - | - | Upgrade
|
Short-Term Debt Repaid | - | -10.52 | -8.37 | - | - | - | Upgrade
|
Long-Term Debt Repaid | - | -112.6 | -334.86 | -24.26 | -14.03 | -14.68 | Upgrade
|
Total Debt Repaid | -125.84 | -123.12 | -343.23 | -24.26 | -14.03 | -14.68 | Upgrade
|
Net Debt Issued (Repaid) | -111.75 | -109.04 | 31.33 | 171.57 | -14.03 | -14.68 | Upgrade
|
Common Dividends Paid | - | - | -7.07 | -31.81 | - | - | Upgrade
|
Financing Cash Flow | -111.75 | -109.04 | 24.27 | 139.76 | -14.03 | -14.68 | Upgrade
|
Net Cash Flow | -16.71 | -16.66 | -22.01 | 11.9 | 24.78 | -37.2 | Upgrade
|
Free Cash Flow | 94.97 | 92.29 | -25.87 | -127.87 | 38.8 | -22.52 | Upgrade
|
Free Cash Flow Growth | 1686.39% | - | - | - | - | - | Upgrade
|
Free Cash Flow Margin | 11.47% | 11.24% | -3.42% | -20.49% | 7.65% | -5.12% | Upgrade
|
Free Cash Flow Per Share | 0.25 | 0.26 | -0.07 | -0.36 | 0.11 | -0.06 | Upgrade
|
Cash Interest Paid | 62.79 | 62.79 | 46.87 | 27.33 | 21.02 | 20.77 | Upgrade
|
Cash Income Tax Paid | 0.07 | 0.07 | - | - | - | - | Upgrade
|
Levered Free Cash Flow | 97.53 | 92.86 | -19.1 | -142.07 | 42.22 | -25.47 | Upgrade
|
Unlevered Free Cash Flow | 125.7 | 123.26 | 1.32 | -124.99 | 55.36 | -12.48 | Upgrade
|
Change in Net Working Capital | -1.9 | -0.96 | 37.82 | 8.26 | -21.05 | 29.97 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.